Nasdaq · Healthcare
CapsoVision, Inc (CV)
As-reported financials and recent SEC filings for CapsoVision, Inc, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$13.6M
Net income
$-25.3M
Net margin
—
Diluted EPS
$-1.03
ROE
-190.9%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2025 |
|---|---|---|
| Revenue | $13.6M | $11.8M |
| Gross profit | $7.2M | $6.4M |
| Operating income | $-25.5M | $-19.9M |
| Net income | $-25.3M | $-19.9M |
| Diluted EPS | $-1.03 | $-0.82 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →32026-07-02
View on EDGAR →8-K2026-07-02
View on EDGAR →42026-07-01
View on EDGAR →4/A2026-07-01
View on EDGAR →42026-07-01
View on EDGAR →42026-07-01
View on EDGAR →42026-07-01
View on EDGAR →Largest Healthcare peers
Go deeper on CV
Search CapsoVision, Inc’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.